LILRB2 and metastatic malignant neoplasm in the lymph nodes: Upregulated ILT2 and ILT4 expression was associated with shorter overall survival, lymph node metastasis and a smaller number of tumor-infiltrating lymphoid cells [16,19,20,21,22,23,24].